Stadler, R. Romero, P.O. Bagot, M. Quaglino, P. Guenova, E. Jonak, C. Papadavid, E. Stranzenbach, R. Sartori, D. Musoro, J.Z. Falato, C. Marreaud, S. Scarisbrick, J.J. Knobler, R., Phase II trial of atezolizumab (anti-PD-L1) in the treatment of stage IIb-IVB mycosis fungoides/Sézary syndrome patients relapsed/refractory after a previous systemic treatment (PARCT), European journal of cancer (Oxford, England : 1990), (156), S22-S23, 2021, NLM (Medline),